Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Insulet
PODD
$11.3B
| $3.6M | ﹤0.01% |
90,867
+693
| +0.8% | +$26.6K |
|
|
CB
527
DELISTED
CHUBB CORPORATION
CB
| $3.55M | ﹤0.01% |
38,471
+19,242
| +100% | +$1.77M |
|
528
Macy's
M
$6.15B
| $3.54M | ﹤0.01% |
61,049
-1,452
| -2% | -$84.3K |
|
529
Deere & Co
DE
$170B
| $3.54M | ﹤0.01% |
+39,100
| New | +$3.6M |
|
|
GRUB
530
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $3.54M | ﹤0.01% |
+49,979
| New | +$3.36M |
|
531
Archer Daniels Midland
ADM
$41.4B
| $3.5M | ﹤0.01% |
79,323
-7,265
| -8% | -$321K |
|
|
K
532
DELISTED
Kellanova
K
| $3.49M | ﹤0.01% |
+56,575
| New | +$3.54M |
|
533
Rockwell Automation
ROK
$51.4B
| $3.32M | ﹤0.01% |
26,561
+669
| +3% | +$82.4K |
|
534
Ford
F
$57.3B
| $3.26M | ﹤0.01% |
+189,321
| New | +$3.08M |
|
535
Berkshire Hathaway Class B
BRK.B
$1.07T
| $3.16M | ﹤0.01% |
24,997
+337
| +1% | +$42.7K |
|
536
AXIS Capital
AXS
$8.59B
| $3.08M | ﹤0.01% |
69,438
+52,414
| +308% | +$2.4M |
|
537
Amgen
AMGN
$203B
| $3.03M | ﹤0.01% |
25,598
-2,561
| -9% | -$296K |
|
|
JIVE
538
DELISTED
Jive Software, Inc.
JIVE
| $2.98M | ﹤0.01% |
349,657
+3,659
| +1% | +$29K |
|
|
OMG
539
DELISTED
OM GROUP INC.
OMG
| $2.87M | ﹤0.01% |
88,636
+27,904
| +46% | +$859K |
|
540
Arch Capital
ACGL
$36.1B
| $2.81M | ﹤0.01% |
146,784
+17,682
| +14% | +$337K |
|
541
DexCom
DXCM
$27.6B
| $2.8M | ﹤0.01% |
282,472
+92,352
| +49% | +$818K |
|
542
Oracle
ORCL
$331B
| $2.73M | ﹤0.01% |
+67,324
| New | +$2.77M |
|
543
Gyre Therapeutics
GYRE
$662M
| $2.72M | ﹤0.01% |
766
-122
| -14% | -$398K |
|
544
Rogers Corp
ROG
$2.33B
| $2.69M | ﹤0.01% |
40,502
-1
| -0% | -$62 |
|
545
Woodward
WWD
$25B
| $2.67M | ﹤0.01% |
53,285
+1
| +0% | +$46 |
|
546
McDonald's
MCD
$188B
| $2.67M | ﹤0.01% |
+26,494
| New | +$2.67M |
|
|
BSFT
547
DELISTED
BroadSoft, Inc.
BSFT
| $2.66M | ﹤0.01% |
100,902
-1,193,532
| -92% | -$28.6M |
|
548
Bloomin' Brands
BLMN
$680M
| $2.65M | ﹤0.01% |
118,198
+1
| +0% | +$22 |
|
549
Assembly Biosciences
ASMB
$506M
| $2.62M | ﹤0.01% |
+33,333
| New | +$2.36M |
|
|
RGLS
550
DELISTED
Regulus Therapeutics
RGLS
| $2.6M | ﹤0.01% |
2,689
-316
| -11% | -$271K |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.